| ASSET | YEAR | % RETURN |
|---|---|---|
Par Pacific (PARR) | 2012 | 1,900% |
Hovnanian Enterprises (HOV) | 2012 | 366.67% |
BioLife Solutions (BLFS) | 2012 | 325% |
Harrow Health (HROW) | 2012 | 306.25% |
Lendingtree (TREE) | 2012 | 241.59% |
Astrana Health (ASTH) | 2012 | 237.84% |
MiMedx (MDXG) | 2012 | 233.91% |
Arbutus Biopharma (ABUS) | 2012 | 208.07% |
Byrna Technologies (BYRN) | 2012 | 207.69% |
CorMedix (CRMD) | 2012 | 177.11% |
HCI (HCI) | 2012 | 176.83% |
Metalla Royalty & Streaming (MTA) | 2012 | 174.49% |
Independent Bank (IBCP) | 2012 | 167.75% |
Transcontinental Realty Investors (TCI) | 2012 | 163.03% |
Xpel (XPEL) | 2012 | 155.56% |
AMN Healthcare Services (AMN) | 2012 | 155.53% |
Stratasys (SSYS) | 2012 | 154.69% |
Celldex Therapeutics (CLDX) | 2012 | 153.21% |
Hudson Technologies (HDSN) | 2012 | 152.78% |
John B Sanfilippo & Son (JBSS) | 2012 | 150.54% |
Himax Technologies (HIMX) | 2012 | 146.61% |
Sharplink Gaming (SBET) | 2012 | 144.83% |
Acadia Healthcare (ACHC) | 2012 | 137.78% |
Heron Therapeuti (HRTX) | 2012 | 136.96% |
Community West Bancshares (CWBC) | 2012 | 135.32% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
